Search
Descriptor English: Extensively Drug-Resistant Tuberculosis
Descriptor Spanish: Tuberculosis Extensivamente Resistente a Drogas
Descriptor tuberculosis extensivamente resistente a múltiples medicamentos
Scope note: Tuberculosis resistente a la ISONICIDA y a la RIFAMPICINA y al menos a tres de las seis clases principales de fármacos de segunda línea (AMINOGLICÓSIDOS, agentes polipeptídicos, FLUOROQUINOLONAS, TIOAMIDAS, CICLOSERINA y ÁCIDO PARAAMINOSALICÍLICO), según lo define el CDC.
Descriptor Portuguese: Tuberculose Extensivamente Resistente a Medicamentos
Descriptor French: Tuberculose ultrarésistante aux médicaments
Entry term(s): Drug-Resistant Tuberculoses, Extensively
Drug-Resistant Tuberculoses, Extremely
Drug-Resistant Tuberculosis, Extensively
Drug-Resistant Tuberculosis, Extremely
Extensively Drug Resistant Tuberculosis
Extensively Drug-Resistant Tuberculoses
Extremely Drug Resistant Tuberculosis
Extremely Drug-Resistant Tuberculoses
Extremely Drug-Resistant Tuberculosis
Tuberculoses, Extensively Drug-Resistant
Tuberculoses, Extremely Drug-Resistant
Tuberculosis, Extensively Drug Resistant
Tuberculosis, Extensively Drug-Resistant
Tuberculosis, Extremely Drug Resistant
Tuberculosis, Extremely Drug-Resistant
XDR-TB
Tree number(s): C01.150.252.410.040.552.846.775.500
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D054908
Scope note: Tuberculosis resistant to ISONIAZID and RIFAMPIN and at least three of the six main classes of second-line drugs (AMINOGLYCOSIDES; polypeptide agents; FLUOROQUINOLONES; THIOAMIDES; CYCLOSERINE; and PARA-AMINOSALICYLIC ACID) as defined by the CDC.
Annotation: coordinate with specific type of tuberculosis + specific antitubercular agents if pertinent
Allowable Qualifiers: BL blood
CF cerebrospinal fluid
CI chemically induced
CL classification
CN congenital
CO complications
DG diagnostic imaging
DH diet therapy
DI diagnosis
DT drug therapy
EC economics
EH ethnology
EM embryology
EN enzymology
EP epidemiology
ET etiology
GE genetics
HI history
IM immunology
ME metabolism
MI microbiology
MO mortality
NU nursing
PA pathology
PC prevention & control
PP physiopathology
PS parasitology
PX psychology
RH rehabilitation
RT radiotherapy
SU surgery
TH therapy
TM transmission
UR urine
VE veterinary
VI virology
Previous Indexing: Tuberculosis, Multidrug-Resistant (2006-2007)
Public MeSH Note: 2008
History Note: 2008
DeCS ID: 52563
Unique ID: D054908
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2008/01/01
Date of Entry: 2007/07/09
Extensively Drug-Resistant Tuberculosis - Preferred
Concept UI M0509462
Scope note Tuberculosis resistant to ISONIAZID and RIFAMPIN and at least three of the six main classes of second-line drugs (AMINOGLYCOSIDES; polypeptide agents; FLUOROQUINOLONES; THIOAMIDES; CYCLOSERINE; and PARA-AMINOSALICYLIC ACID) as defined by the CDC.
Preferred term Extensively Drug-Resistant Tuberculosis
Entry term(s) Drug-Resistant Tuberculoses, Extensively
Drug-Resistant Tuberculoses, Extremely
Drug-Resistant Tuberculosis, Extensively
Drug-Resistant Tuberculosis, Extremely
Extensively Drug Resistant Tuberculosis
Extensively Drug-Resistant Tuberculoses
Extremely Drug Resistant Tuberculosis
Extremely Drug-Resistant Tuberculoses
Extremely Drug-Resistant Tuberculosis
Tuberculoses, Extensively Drug-Resistant
Tuberculoses, Extremely Drug-Resistant
Tuberculosis, Extensively Drug Resistant
Tuberculosis, Extensively Drug-Resistant
Tuberculosis, Extremely Drug Resistant
Tuberculosis, Extremely Drug-Resistant
XDR-TB



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey